Cederquist represents Cytel in connection with its acquisition of SDS Life Science and SDS MedteQ

Cederquist represents Cytel Inc., a leading provider of statistical software and advanced analytics for clinical trial design and execution, in connection with its acquisition of SDS Life Science and SDS MedteQ. SDS Life Science provides the pharmaceutical industry with consultancy services within drug development, regulatory affairs, biostatistics, clinical project management and real-world evidence. SDS MedteQ provides medtech consulting services and expertise within regulatory affairs, quality assurance, clinical development, and compliance project management.

Cederquist’s team is led by partner Pontus Röckert (M&A) and senior associate Isabel Cantos (M&A), assisted primarily by associates Mark Gebert (M&A), Fanny Fernlöf (M&A) and Malin Dunér (Employment), with the support of other specialist groups engaged in the transaction.

For further information, please refer to the press release published by Cytel at https://www.cytel.com/news/cytel-to-acquire-sds-life-science-and-sds-medteq.